Popular topics
Health technology, digital therapeutics, biotech, and the slow remaking of medical practice through software and devices.
705 articles · Health Tech & Medtech
Krista Varady has been studying intermittent fasting for two decades at the University of Illinois Chicago, and in a 2024 commentary, she and her co-authors set out to systematically debunk four common safety myths about the practice.
Roughly one in eight American adults is now taking a GLP-1 drug like Ozempic, Wegovy or Zepbound. The class traces back to a hormone isolated from Gila monster venom by a Bronx doctor who paid a dollar to file the patent himself after his employer passed on it.
Ozempic lists for roughly $969 in the United States and around €59 in Germany — the same pen, the same molecule, made in the same Danish factory. The reason winds back to a Nobel laureate's 1922 trip to Toronto.
The future of liver disease treatment may arrive not on a surgical table, but through a syringe.
A study published in Nature Communications found that a 50 per cent chance of pain is more stressful than pain itself — which reframes premature decisions as a coping mechanism, not a personality trait.
Cell reprogramming — the technique of returning adult cells to a more youthful state using four genetic factors identified in Nobel Prize-winning research — has become the buzziest approach in longevity science, displacing earlier obsessions with telomere lengthening and senolytic drugs.
In July 1969, Apollo 11's crew was sealed in an Airstream trailer for 21 days while NASA tested moon rocks for life that wasn't there — meanwhile, the ocean beneath their splashdown site held vampire squid, 40-meter siphonophores, and single-celled organisms the size of dinner plates.
Amsterdam’s Healthplus.ai has raised €2.3M to develop further and expand its AI technology, designed to support hospitals in managing surgical care.
Dutch AI company Guideways, helping medtech businesses navigate regulatory and compliance, has raised pre-seed financing.
AstraZeneca finalises buyout of SixPeaks Bio to accelerate advanced obesity treatment pipeline.
YON E Health raises €250K to develop tech that supports early detection and data-driven insights in women’s reproductive and vaginal health.
Warsaw-based Holi has completed a new funding round to grow its operations and expand its digital health services in Europe.
